La
Non vérifié

Latus Bio, Inc.

Ce que nous écrivons

BiotechnologieIndustrieSantéSanté PubliqueScience
30/10/2026
Événements
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé Publique
Santé
Latus Bio Announces New Preclinical Data Featuring High-Performing Engineered AAV Capsid Variants for Kidney and CNS Diseases at ESGCT 33rd Annual Congress
1.00
15/10/2026
Science
Biotechnologie
Santé Publique
Industrie pharmaceutique
Santé
Événements
Latus Bio to Participate In Chardan's 10th Annual Healthcare Conference
1.00
13/10/2026
Santé
Santé Publique
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Événements
Industrie
Latus Bio Announces Four Abstracts Selected for Presentation at the European Society of Gene and Cell Therapy 33rd Annual Congress
1.00
05/10/2026
Événements
Expos
Santé
Biotechnologie
Santé Publique
Médecine - Divers
Science
Latus Bio Announces New Data Presentation at American Society of Nephrology (ASN) Kidney Week 2026
1.00
09/09/2026
Marché du travail
Santé
Biotechnologie
Médecine - Divers
Science
Industrie pharmaceutique
Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair
1.00
16/06/2026
Marché du travail
Science
Biotechnologie
Médecine - Divers
Santé
Industrie pharmaceutique
Santé Publique
Latus Bio Appoints Bethany Mancilla as Chief Business Officer
1.00
04/05/2026
Science
Biotechnologie
Médecine - Divers
Santé
Industrie pharmaceutique
Santé Publique
Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations
1.00
28/04/2026
Événements
Expos
Industrie
Science
Biotechnologie
Santé Publique
Santé
Médecine - Divers
Latus Bio to Present New Data at ASGCT 2026 Supporting Investigational Gene Therapy Approaches for Huntington’s Disease and CLN2 Disease
1.00
02/12/2025
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé
Enfance
Vitrines/Shopping
Latus Bio Announces IND Clearance of LTS-101 for CLN2 Disease and Receipt of Fast Track, Orphan Drug, and Rare Pediatric Disease Designations
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0